Global Low-Concentration Atropine Market 2024-2028

Global Low-Concentration Atropine Market 2024-2028


The low-concentration atropine market is forecasted to grow by USD 1,039.97 mn during 2023-2028, accelerating at a CAGR of 18.81% during the forecast period. The report on the low-concentration atropine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of myopia, rising awareness regarding vision care, and growing demand for vision correction among aging population.

Technavio's low-concentration atropine market is segmented as below:

By Type

Atropine sulfate 0.01 percentage
Atropine sulfate 0.025 percentage
Atropine sulfate 0.05 percentage

By Application

Child
Adult

By Geography

Asia
North America
Europe
Rest of World (ROW)

This study identifies the growing number of clinical trials by market vendors as one of the prime reasons driving the low-concentration atropine market growth during the next few years. Also, growing focus on funding for myopia research studies and increase in partnership by market vendors will lead to sizable demand in the market.

The report on the low-concentration atropine market covers the following areas:

Low-concentration atropine market sizing
Low-concentration atropine market forecast
Low-concentration atropine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading low-concentration atropine market vendors that include AdvaCare Pharma, Aurolab, Bausch Lomb Corp., ENTOD INTERNATIONAL, Eyenovia Inc., Gmt Pharma, Grevis Pharmaceuticals Pvt. Ltd., ISKON REMEDIES and GMT, Jawa Pharmaceuticals India Pvt. Ltd., Medizia Biotech, OSRX Inc., Raymed Pharmaceutical Ltd., Santen Pharmaceutical Co. Ltd., Sydnexis Inc., Tache Pharmacy, Taiwan Biotech Co.,Ltd, Vyluma, and Aspire Pharma Ltd. Also, the low-concentration atropine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global low-concentration atropine market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028
Exhibit 34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
6.4 Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028
Exhibit 38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
6.5 Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028
Exhibit 42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 48: Chart on Application - Market share 2023-2028 (%)
Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 50: Chart on Comparison by Application
Exhibit 51: Data Table on Comparison by Application
7.3 Child - Market size and forecast 2023-2028
Exhibit 52: Chart on Child - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Child - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Child - Year-over-year growth 2023-2028 (%)
7.4 Adult - Market size and forecast 2023-2028
Exhibit 56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Adult - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Application
Exhibit 60: Market opportunity by Application ($ million)
Exhibit 61: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share by geography 2023-2028 (%)
Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
Exhibit 67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 103: Market opportunity by geography ($ million)
Exhibit 104: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AdvaCare Pharma
Exhibit 111: AdvaCare Pharma - Overview
Exhibit 112: AdvaCare Pharma - Product / Service
Exhibit 113: AdvaCare Pharma - Key offerings
12.4 Bausch Lomb Corp.
Exhibit 114: Bausch Lomb Corp. - Overview
Exhibit 115: Bausch Lomb Corp. - Business segments
Exhibit 116: Bausch Lomb Corp. - Key news
Exhibit 117: Bausch Lomb Corp. - Key offerings
Exhibit 118: Bausch Lomb Corp. - Segment focus
12.5 ENTOD INTERNATIONAL
Exhibit 119: ENTOD INTERNATIONAL - Overview
Exhibit 120: ENTOD INTERNATIONAL - Key offerings
12.6 Eyenovia Inc.
Exhibit 121: Eyenovia Inc. - Overview
Exhibit 122: Eyenovia Inc. - Key offerings
12.7 Gmt Pharma
Exhibit 123: Gmt Pharma - Overview
Exhibit 124: Gmt Pharma - Product / Service
Exhibit 125: Gmt Pharma - Key offerings
12.8 ISKON REMEDIES and GMT
Exhibit 126: ISKON REMEDIES and GMT - Overview
Exhibit 127: ISKON REMEDIES and GMT - Product / Service
Exhibit 128: ISKON REMEDIES and GMT - Key offerings
12.9 Jawa Pharmaceuticals INDIA Pvt. Ltd.
Exhibit 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
Exhibit 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
Exhibit 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
12.10 Medizia Biotech
Exhibit 132: Medizia Biotech - Overview
Exhibit 133: Medizia Biotech - Product / Service
Exhibit 134: Medizia Biotech - Key offerings
12.11 OSRX Inc.
Exhibit 135: OSRX Inc. - Overview
Exhibit 136: OSRX Inc. - Product / Service
Exhibit 137: OSRX Inc. - Key offerings
12.12 Raymed Pharmaceutical Ltd.
Exhibit 138: Raymed Pharmaceutical Ltd. - Overview
Exhibit 139: Raymed Pharmaceutical Ltd. - Product / Service
Exhibit 140: Raymed Pharmaceutical Ltd. - Key offerings
12.13 Santen Pharmaceutical Co. Ltd.
Exhibit 141: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 142: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 143: Santen Pharmaceutical Co. Ltd. - Key offerings
12.14 Sydnexis Inc.
Exhibit 144: Sydnexis Inc. - Overview
Exhibit 145: Sydnexis Inc. - Product / Service
Exhibit 146: Sydnexis Inc. - Key offerings
12.15 Tache Pharmacy
Exhibit 147: Tache Pharmacy - Overview
Exhibit 148: Tache Pharmacy - Product / Service
Exhibit 149: Tache Pharmacy - Key offerings
12.16 Taiwan Biotech Co.,Ltd
Exhibit 150: Taiwan Biotech Co.,Ltd - Overview
Exhibit 151: Taiwan Biotech Co.,Ltd - Product / Service
Exhibit 152: Taiwan Biotech Co.,Ltd - Key offerings
12.17 Vyluma
Exhibit 153: Vyluma - Overview
Exhibit 154: Vyluma - Product / Service
Exhibit 155: Vyluma - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 156: Inclusions checklist
Exhibit 157: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 158: Currency conversion rates for US$
13.4 Research methodology
Exhibit 159: Research methodology
Exhibit 160: Validation techniques employed for market sizing
Exhibit 161: Information sources
13.5 List of abbreviations
Exhibit 162: List of abbreviations
Exhibits :
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Type ($ million)
Exhibits 47: Data Table on Market opportunity by Type ($ million)
Exhibits 48: Chart on Application - Market share 2023-2028 (%)
Exhibits 49: Data Table on Application - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by Application
Exhibits 51: Data Table on Comparison by Application
Exhibits 52: Chart on Child - Market size and forecast 2023-2028 ($ million)
Exhibits 53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Chart on Child - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Child - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
Exhibits 57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Chart on Adult - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by Application ($ million)
Exhibits 61: Data Table on Market opportunity by Application ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share by geography 2023-2028 (%)
Exhibits 64: Data Table on Market share by geography 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity by geography ($ million)
Exhibits 104: Data Tables on Market opportunity by geography ($ million)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: AdvaCare Pharma - Overview
Exhibits 112: AdvaCare Pharma - Product / Service
Exhibits 113: AdvaCare Pharma - Key offerings
Exhibits 114: Bausch Lomb Corp. - Overview
Exhibits 115: Bausch Lomb Corp. - Business segments
Exhibits 116: Bausch Lomb Corp. - Key news
Exhibits 117: Bausch Lomb Corp. - Key offerings
Exhibits 118: Bausch Lomb Corp. - Segment focus
Exhibits 119: ENTOD INTERNATIONAL - Overview
Exhibits 120: ENTOD INTERNATIONAL - Key offerings
Exhibits 121: Eyenovia Inc. - Overview
Exhibits 122: Eyenovia Inc. - Key offerings
Exhibits 123: Gmt Pharma - Overview
Exhibits 124: Gmt Pharma - Product / Service
Exhibits 125: Gmt Pharma - Key offerings
Exhibits 126: ISKON REMEDIES and GMT - Overview
Exhibits 127: ISKON REMEDIES and GMT - Product / Service
Exhibits 128: ISKON REMEDIES and GMT - Key offerings
Exhibits 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
Exhibits 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
Exhibits 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
Exhibits 132: Medizia Biotech - Overview
Exhibits 133: Medizia Biotech - Product / Service
Exhibits 134: Medizia Biotech - Key offerings
Exhibits 135: OSRX Inc. - Overview
Exhibits 136: OSRX Inc. - Product / Service
Exhibits 137: OSRX Inc. - Key offerings
Exhibits 138: Raymed Pharmaceutical Ltd. - Overview
Exhibits 139: Raymed Pharmaceutical Ltd. - Product / Service
Exhibits 140: Raymed Pharmaceutical Ltd. - Key offerings
Exhibits 141: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits 142: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits 143: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits 144: Sydnexis Inc. - Overview
Exhibits 145: Sydnexis Inc. - Product / Service
Exhibits 146: Sydnexis Inc. - Key offerings
Exhibits 147: Tache Pharmacy - Overview
Exhibits 148: Tache Pharmacy - Product / Service
Exhibits 149: Tache Pharmacy - Key offerings
Exhibits 150: Taiwan Biotech Co.,Ltd - Overview
Exhibits 151: Taiwan Biotech Co.,Ltd - Product / Service
Exhibits 152: Taiwan Biotech Co.,Ltd - Key offerings
Exhibits 153: Vyluma - Overview
Exhibits 154: Vyluma - Product / Service
Exhibits 155: Vyluma - Key offerings
Exhibits 156: Inclusions checklist
Exhibits 157: Exclusions checklist
Exhibits 158: Currency conversion rates for US$
Exhibits 159: Research methodology
Exhibits 160: Validation techniques employed for market sizing
Exhibits 161: Information sources
Exhibits 162: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings